For instance, astrocytes in the VTA express higher levels of the neuroprotective factor growth/differentiation factor 15 (GDF15) compared to those in the SN, providing enhanced protection for VTA dopaminergic neurons against PD-related toxicity [25]. This evidence concerns the gene GDF15 and Parkinson disease.